US Market Report for Insulin Pumps 2017 – MedCore

US Market Report for Insulin Pumps 2017 – MedCore


  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 11/1/16
  • Pages: 73
  • Type: MedCore

Traditional insulin pumps, often referred to as durable pumps, offer constant and finer delivery of insulin to maintain precise control of glycemic levels. Traditional pumps feature a reservoir of insulin connected to the patient through plastic tubing and a cannula, referred to as an infusion set. A small computer controls the dosage, and is pre-programmed specifically for the patient. The insulin pump is used to deliver both basal and bolus insulin. Basal insulin is delivered continuously at a rate set by the user specific to the time of day. Bolus insulin is injected prior to eating based on what the patient plans to eat and their current blood glucose level. Infusion sets are typically replaced once every three days, while insulin reservoirs are typically replaced once every two to three days. New technological innovations in the traditional pump market include pumps with built-in continuous glucose monitoring (CGM), low glucose suspension algorithms and touchscreen interfaces.

The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional pump segment. Traditional pumps account for such a large portion of the market because they are a much more established market, relative to the patch pump and simple pump markets, which were launched in the U.S. in 2005 and 2012, respectively. It is expected that traditional pumps will maintain their dominance over the forecast period, despite the growing market share of patch pumps and simple pumps. Patch pumps are an attractive therapy option for the proportion of the patient population that values the wireless features and significant cost savings on the initial investment of the device, relative to traditional pumps. Although Insulet Corporation currently holds a monopoly in the U.S. market, Cellnovo and other competitors are expected to launch patch pump products over the forecast period and contribute to increased device uptake among the insulin-dependent diabetic population.

The "US Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Novo Nordisk
Eli Lilly
Johnson & Johnson
Becton Dickinson
Trividia Health
Nova Biomedical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

Already have an account? Sign in